Why is Estrogen therapy a risk factor for deep vein thrombosis?

Estrogen therapy can increase the risk of deep vein thrombosis (DVT) because it affects the coagulation system by promoting a hypercoagulable state. Estrogen enhances the production of certain clotting factors in the liver while reducing the levels of anticoagulant proteins, leading to an increased tendency for blood to clot. Additionally, estrogen can cause changes in the vascular endothelium and reduce blood flow, both of which contribute to the formation of clots in the veins. This risk is particularly heightened in individuals with pre-existing conditions or additional risk factors for thrombosis.